Effect of chemotherapy on sex hormone levels in adolescents with acute lymphoblastic leukemia

Objective. To evaluate the levels of sex hormones: estrone (E1), estradiol (E2), estriol (E3), progesterone (P4), testosterone (T), and free testosterone (FT), as well as their receptors: estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), androgen receptor (AR), and sex hormone-binding globulin (SHBG), in adolescents with acute lymphoblastic leukemia (ALL) before treatment initiation and after completion of the remission consolidation phase. Materials and methods. The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Levels of sex hormones (E1, E2, E3, P4, T, FT), their receptors (ERα, ERβ, AR), and SHBG were measured before treatment and after completion of remission consolidation using enzyme-linked immunosorbent assay (ELISA). Data from apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls with ALL (n=20), before treatment E1 decreased 46.5-fold, E3 1.5-fold, P4 34.2-fold, T 16.0-fold, and FT 28.3-fold, while E2 and SHBG increased 3.9-fold and 2.2-fold, respectively. After consolidation phase III, E1 increased 51.8-fold, E2 decreased 3.9-fold and normalized, whereas E3, P4, T, and FT remained below normal values by 10.0-, 15.2-, 2.7-, and 4.3-fold, respectively. ERα and ERβ exceeded normal values by 1.4- and 2.2-fold, respectively, while SHBG remained elevated 2.2-fold. In boys with ALL (n=20), before treatment E1 decreased 1.7-fold, E2 3.1-fold, P4 4.3-fold, T 21.0-fold, and FT 5.6-fold, while SHBG increased 1.5-fold. After consolidation phase III, E1 exceeded normal values 1.6-fold in 50.0 % (n=10) of boys and remained 4.5-fold below normal in the remaining 50 % (n=10). E2, E3, and P4 remained below normal values by 1.6-, 2.2-, and 1.8-fold, respectively. In 50 % (n=10) of boys, T exceeded normal values 2.9-fold, whereas in the remaining 50 % (n=10) it remained 5.3-fold below normal. FT and AR remained below normal values by 2.9- and 2.0-fold, respectively. SHBG remained elevated 1.8-fold. Conclusion. The obtained data indicate the necessity for dynamic endocrinological monitoring of adolescents with ALL during chemotherapy. The identified disturbances in hormonal profile, as well as alterations in SHBG, ERα, ERβ, and AR levels, require comprehensive assessment and, when necessary, individualized correction in collaboration with a pediatric endocrinologist.

Authors

Institutions

Publication Details

Journal
Medical alphabet
Published
2026-11-17
DOI
https://doi.org/10.33667/2078-5631-2026-27-36-42
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of chemotherapy on sex hormone levels in adolescents with acute lymphoblastic leukemia

Yu. Yu. Kozel, Sergey N Dimitriadi, Дмитриева Виктория Викторовна, Elena Mikhaylovna Frantsiyants et al.
Medical alphabet
Acute Lymphoblastic Leukemia research
article

Effect of chemotherapy on sex hormone levels in adolescents with acute lymphoblastic leukemia

Yu. Yu. Kozel, Sergey N Dimitriadi, Дмитриева Виктория Викторовна, Elena Mikhaylovna Frantsiyants, Valeriya Akhtyamovna Bandovkina, Daniil A. Dzhavadov, Olga V. Kozyuk
article en

Abstract

Objective. To evaluate the levels of sex hormones: estrone (E1), estradiol (E2), estriol (E3), progesterone (P4), testosterone (T), and free testosterone (FT), as well as their receptors: estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), androgen receptor (AR), and sex hormone-binding globulin (SHBG), in adolescents with acute lymphoblastic leukemia (ALL) before treatment initiation and after completion of the remission consolidation phase. Materials and methods. The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Levels of sex hormones (E1, E2, E3, P4, T, FT), their receptors (ERα, ERβ, AR), and SHBG were measured before treatment and after completion of remission consolidation using enzyme-linked immunosorbent assay (ELISA). Data from apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls with ALL (n=20), before treatment E1 decreased 46.5-fold, E3 1.5-fold, P4 34.2-fold, T 16.0-fold, and FT 28.3-fold, while E2 and SHBG increased 3.9-fold and 2.2-fold, respectively. After consolidation phase III, E1 increased 51.8-fold, E2 decreased 3.9-fold and normalized, whereas E3, P4, T, and FT remained below normal values by 10.0-, 15.2-, 2.7-, and 4.3-fold, respectively. ERα and ERβ exceeded normal values by 1.4- and 2.2-fold, respectively, while SHBG remained elevated 2.2-fold. In boys with ALL (n=20), before treatment E1 decreased 1.7-fold, E2 3.1-fold, P4 4.3-fold, T 21.0-fold, and FT 5.6-fold, while SHBG increased 1.5-fold. After consolidation phase III, E1 exceeded normal values 1.6-fold in 50.0 % (n=10) of boys and remained 4.5-fold below normal in the remaining 50 % (n=10). E2, E3, and P4 remained below normal values by 1.6-, 2.2-, and 1.8-fold, respectively. In 50 % (n=10) of boys, T exceeded normal values 2.9-fold, whereas in the remaining 50 % (n=10) it remained 5.3-fold below normal. FT and AR remained below normal values by 2.9- and 2.0-fold, respectively. SHBG remained elevated 1.8-fold. Conclusion. The obtained data indicate the necessity for dynamic endocrinological monitoring of adolescents with ALL during chemotherapy. The identified disturbances in hormonal profile, as well as alterations in SHBG, ERα, ERβ, and AR levels, require comprehensive assessment and, when necessary, individualized correction in collaboration with a pediatric endocrinologist.

Medical alphabet(27)
Ministry of Health of the Russian Federation (RU)
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon